Discover 1,760 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,760
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
for
Advanced Adenocarcinoma
Location: Detroit MI, Cleveland OH, Chicago IL, Cincinnati OH,
Sponsor: BioAtla, Inc.
Sex: All
Age: 18+
Code: NCT05808634
Phase 1, Recruiting
Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
Location: Detroit MI, Columbus OH, Rochester MN, Philadelphia PA,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT06626919
Phase 1, Recruiting
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
for
Large Cell Lymphoma, Diffuse, Relapsed Cancer,
Location: Detroit MI, Indianapolis IN, Charlottesville VA,
Sponsor: Dipenkumar Modi
Sex: All
Age: 18+
Code: NCT05852717
Phase 2, Recruiting
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
for
Chronic Phase Chronic Myelogenous Leukemia
Location: Detroit MI, Milwaukee WI, Buffalo NY, New York NY,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04838041
Phase 2, Recruiting
Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis
for
Light Chain (AL) Amyloidosis
Location: Detroit MI, Milwaukee WI, Boston MA, Duarte CA
Sponsor: Sorrento Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04316442
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
for
Recurrent Endometrial Carcinoma,
Location: Detroit MI, Cleveland OH, Columbus OH, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05950464
Phase 1, Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Detroit MI, Cleveland OH, Columbus OH, Zion IL,
Sponsor: J-Pharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07265674
Phase 3, Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Detroit MI, Arlington Heights IL, Lake Barrington IL,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05413421
Phase 1, Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
for
Systemic Lupus Erythematosus (SLE),
Location: Troy MI, Atlanta GA, Allen TX, Tampa FL, Tamarac FL,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07332481
Phase 3, Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Location: Auburn Hills MI, Indianapolis IN, Charlotte NC,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07355218
Phase 3, Recruiting
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
for
Solid Tumor
Location: Detroit MI, Iowa City IA, Newark DE, Hackensack NJ,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT05584670
Phase 1, Phase 2, Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies